Indications and uses
Lack of Vitality
Lack of Vitality
Store in a cool dark place
CALCAREA PHOSPHORICA 3X HPUS, KALI PHOSPHORICUM 3X HPUS, NATRUM MURIATICUM 6X HPUS
Lack of Vitality
Condition listed above or as directed by the physician
Adults- Take 4 or 6 tablets by mouth, three times daily or as suggested by physician. Children 2 years and older- take 1/2 the adult dose.
This product is to be used for self-limiting conditions.
If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional
As with any drug, if you are preganant, or nursing a baby, seek professional advice before taking this product
Keep this and all medication out of reach of children
Do not use if capseal is broken or missing.
Close the cap tightly after use.
Lactose
Store in a cool dark place
www.rxhomeo.com | 1.888.2796642 | info@rxhomeo.com
Rxhomeo, Inc 9415 Burnet Road, Suite 312, Austin, TX 78758
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 15631-2382-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1f06-f424-e053-dadaa90a57ce | cc613cd1-180c-43f7-8f83-c9d1e43cecb0 |
| 15631-2382-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1f06-f424-e053-dadaa90a57ce | cc613cd1-180c-43f7-8f83-c9d1e43cecb0 |
| 15631-2382-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1f06-f424-e053-dadaa90a57ce | cc613cd1-180c-43f7-8f83-c9d1e43cecb0 |
| 15631-2382-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1f06-f424-e053-dadaa90a57ce | cc613cd1-180c-43f7-8f83-c9d1e43cecb0 |
| 15631-2382-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1f06-f424-e053-dadaa90a57ce | cc613cd1-180c-43f7-8f83-c9d1e43cecb0 |
| 15631-2382-5 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1f06-f424-e053-dadaa90a57ce | cc613cd1-180c-43f7-8f83-c9d1e43cecb0 |
| 15631-2382-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1f06-f424-e053-dadaa90a57ce | cc613cd1-180c-43f7-8f83-c9d1e43cecb0 |
| 15631-2382-7 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1f06-f424-e053-dadaa90a57ce | cc613cd1-180c-43f7-8f83-c9d1e43cecb0 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 15631-2382-0 | Bio-Combination 27 | 1 in 1 BLISTER PACK | TABLET | 1 | 2 | |
| 15631-2382-1 | Bio-Combination 27 | 4 in 1 BLISTER PACK | TABLET | 4 | 2 | |
| 15631-2382-2 | Bio-Combination 27 | 50 in 1 CONTAINER | TABLET | 50 | 2 | |
| 15631-2382-3 | Bio-Combination 27 | 100 in 1 CONTAINER | TABLET | 100 | 2 | |
| 15631-2382-4 | Bio-Combination 27 | 250 in 1 CONTAINER | TABLET | 250 | 2 | |
| 15631-2382-5 | Bio-Combination 27 | 500 in 1 CONTAINER | TABLET | 500 | 2 | |
| 15631-2382-6 | Bio-Combination 27 | 1000 in 1 CONTAINER | TABLET | 1000 | 2 | |
| 15631-2382-7 | Bio-Combination 27 | 10000 in 1 CONTAINER | TABLET | 10000 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 15631-2382 | BIO-COMBINATION 27 (CALCAREA PHOSPHORICA, KALI PHOSPHORICUM, NATRUM MURIATICUM) TABLET [RXHOMEO PRIVATE LIMITED D.B.A. RXHOMEO, INC] | 2 | Legacy NDC, 8 package rows | 20160412_cc613cd1-180c-43f7-8f83-c9d1e43cecb0.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 15631-2382 | 15631-2382-0, 15631-2382-1, 15631-2382-2, 15631-2382-3, 15631-2382-4, 15631-2382-5, 15631-2382-6, 15631-2382-7 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TRIBASIC CALCIUM PHOSPHATE | 91D9GV0Z28 | ACTIM |
| POTASSIUM PHOSPHATE, DIBASIC | CI71S98N1Z | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| LACTOSE | J2B2A4N98G | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 65aaced0-c425-4aff-9ce2-c71efcd58a03 | cc613cd1-180c-43f7-8f83-c9d1e43cecb0 | 2016-04-11 | Warnings | 65aaced0-c425-4aff-9ce2-c71efcd58a03 cc613cd1-180c-43f7-8f83-c9d1e43cecb0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.